[Corrigendum] Downregulation of cytokeratin 18 is associated with paclitaxel‑resistance and tumor aggressiveness in prostate cancer.

After the publication of the article, the authors noted that they would like to add Dr Robert H. Getzenberg's name to the authors' list and as a co-corresponding author, upon the agreement of all the authors. The correct author list should be as follows: BO YIN1, MO ZHANG1, YU ZENG2,3*, YOUQIANG LI3, CHAO ZHANG1, ROBERT H. GETZENBERG3* and YONGSHENG SONG1* 1Department of Urology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004; 2Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China; 3James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21087, USA Correspondence should now be addressed to: Correspondence to: Dr Yongsheng Song, Department of Urology, Shengjing Hospital of China Medical University, 36 Sanhao Street, Shenyang, Liaoning 110004, P.R. China E-mail: yinbowzf@163.com Dr Robert H. Getzenberg, James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21087, USA E-mail: getzenberg@outlook.com *Contributed equally [the original article was published in the International Journal of Oncology 48: 1730-1736, 2016; DOI: 10.3892/ijo.2016.3396].